Retatrutide 10mg

Retatrutide (LY3437943) is an investigational peptide designed to activate three metabolic receptor pathways: GLP-1, GIP and glucagon. Research programs are examining its effects on metabolic physiology, energy balance and body-weight-related outcomes. Its tri-agonist mechanism is a defining feature of the compound.Research-use reference: Retatrutide is investigational. This catalogue text does not provide medical advice, dosage information or a claim of approval for human use.